Top Markets
Coin of the day
Proteomics International Laboratories Ltd. Proteomics International Laboratories Ltd.

Proteomics International Laboratories Ltd.

PIQ
Clasificación en acciones #30135
Proteomics International Laboratories Ltd operates as a medical technology... Proteomics International Laboratories Ltd operates as a medical technology company with a focus on the area of proteomics in Australia, New Zealand, the United States, Europe, India, and Southeast Asia. It provides PromarkerD, a blood test to predict diabetic kidney disease (DKD). The company’s products under development include PromarkerEndo, which has completed clinical validation phase for endometriosis diagnosis; PromarkerEso, which has completed clinical validation trials for esophageal cancer diagnosis; and OxiDx (2-tag), which has completed clinical validation phase for oxidative stress treatment. It is also developing diagnostic tests for that includes DKD - T1D, that is under clinical phase for type 1 diabetes, diabetic retinopathy, and diabetic neuropathy; Asthma and COPD, which has completed proof-of-concept study trials for asthma and chronic obstructive pulmonary disease; Plant Dieback, that is under development phase for phytophthora dieback; Diabetic Retinopathy, which has completed discovery phase for sight-threatening retinopathy; and Diabetic Neuropathy, that is under research phase to investigate predictive biomarkers for diabetic neuropathy. The company also offers analytical services, such as specialist contract research focusing on biomarker discovery, biosimilars quality control, and pharmacokinetic testing for clinical trials. It has strategic collaboration with Harry Perkins Institute of Medical Research, Bioplatforms Australia, The University of Western Australia, Australian Research Council Training Centre, and the Australian Centre. Proteomics International Laboratories Ltd was founded in 2001 and is based in Perth, Australia.
Precio por acción
$0.11284557
Capitalización bursátil
$18.66M
Cambio (1 día)
3.23%
Cambio (1 año)
-47.82%
País
AU
Comercio Proteomics International Laboratories Ltd. (PIQ)

Categoría

Historial del precio de la acción de Proteomics International Laboratories Ltd. (PIQ)
Precio más alto de cierre: $0.11 el 2026-08-01

Precio más bajo de cierre: $0.16 el 2014-12-01
Historial del precio de la acción de Proteomics International Laboratories Ltd. desde 2014 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2026 (TTM) -33.71%
2025 -19.76%
2024 -27.38%
2023 -5.58%
2022 -26.46%
2021 53.04%
2020 172.55%
2019 -31.28%
2018 54.75%
2017 -0.71%
2016 -16.75%
2015 36.47%
2014 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
$411.64 2.22%
US
$55.43 2.00%
DE
$63.01 -6.18%
SA
$270.25 51.80%
US
$2.12 30.64%
MY